FOXP3 expression has been reported in several tumors such as melanoma, pancreatic cancer, breast cancer and lung cancer (and is referred to as cancer-FOXP3) despite its non-redundant role in the regulation of Treg cell differentiation, development and functions (104, 105). This evidence concerns the gene FOXP3 and familial pancreatic carcinoma.